{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:40:24Z","timestamp":1772829624699,"version":"3.50.1"},"publisher-location":"Cham","reference-count":146,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030312053","type":"print"},{"value":"9783030312060","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-030-31206-0_10","type":"book-chapter","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T08:03:08Z","timestamp":1577952188000},"page":"195-213","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Cellular Therapy for Ischemic Heart Disease: An Update"],"prefix":"10.1007","author":[{"given":"Hsuan","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Abdel-Latif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,3]]},"reference":[{"key":"10_CR1","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","volume":"139","author":"EJ Benjamin","year":"2019","unstructured":"Benjamin EJ et al (2019) Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation 139:e56\u2013e66. https:\/\/doi.org\/10.1161\/CIR.0000000000000659","journal-title":"Circulation"},{"key":"10_CR2","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nbt1117","volume":"23","author":"MA Laflamme","year":"2005","unstructured":"Laflamme MA, Murry CE (2005) Regenerating the heart. Nat Biotechnol 23:845\u2013856. https:\/\/doi.org\/10.1038\/nbt1117","journal-title":"Nat Biotechnol"},{"key":"10_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fcvm.2017.00047","volume":"4","author":"YY Leong","year":"2017","unstructured":"Leong YY, Ng WH, Ellison-Hughes GM, Tan JJ (2017) Cardiac stem cells for myocardial regeneration: they are not alone. Front Cardiovasc Med 4:47. https:\/\/doi.org\/10.3389\/fcvm.2017.00047","journal-title":"Front Cardiovasc Med"},{"key":"10_CR4","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/385810a0","volume":"385","author":"I Wilmut","year":"1997","unstructured":"Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH (1997) Viable offspring derived from fetal and adult mammalian cells. Nature 385:810\u2013813. https:\/\/doi.org\/10.1038\/385810a0","journal-title":"Nature"},{"key":"10_CR5","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","volume":"282","author":"JA Thomson","year":"1998","unstructured":"Thomson JA et al (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:1145\u20131147","journal-title":"Science"},{"key":"10_CR6","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663\u2013676. https:\/\/doi.org\/10.1016\/j.cell.2006.07.024","journal-title":"Cell"},{"key":"10_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nature05934","volume":"448","author":"K Okita","year":"2007","unstructured":"Okita K, Ichisaka T, Yamanaka S (2007) Generation of germline-competent induced pluripotent stem cells. Nature 448:313\u2013317. https:\/\/doi.org\/10.1038\/nature05934","journal-title":"Nature"},{"key":"10_CR8","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861\u2013872. https:\/\/doi.org\/10.1016\/j.cell.2007.11.019","journal-title":"Cell"},{"key":"10_CR9","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.stem.2010.12.008","volume":"8","author":"SJ Kattman","year":"2011","unstructured":"Kattman SJ et al (2011) Stage-specific optimization of activin\/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 8:228\u2013240. https:\/\/doi.org\/10.1016\/j.stem.2010.12.008","journal-title":"Cell Stem Cell"},{"key":"10_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/cr.2011.195","volume":"22","author":"N Cao","year":"2012","unstructured":"Cao N et al (2012) Ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells. Cell Res 22:219\u2013236. https:\/\/doi.org\/10.1038\/cr.2011.195","journal-title":"Cell Res"},{"key":"10_CR11","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1161\/CIRCULATIONAHA.116.024692","volume":"135","author":"TM Mohamed","year":"2017","unstructured":"Mohamed TM et al (2017) Chemical enhancement of in vitro and in vivo direct cardiac reprogramming. Circulation 135:978\u2013995. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.024692","journal-title":"Circulation"},{"key":"10_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.cell.2018.02.014","volume":"173","author":"TMA Mohamed","year":"2018","unstructured":"Mohamed TMA et al (2018) Regulation of cell cycle to stimulate adult cardiomyocyte proliferation and cardiac regeneration. Cell 173:104\u2013116.e112. https:\/\/doi.org\/10.1016\/j.cell.2018.02.014","journal-title":"Cell"},{"key":"10_CR13","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.cell.2010.07.002","volume":"142","author":"M Ieda","year":"2010","unstructured":"Ieda M et al (2010) Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142:375\u2013386. https:\/\/doi.org\/10.1016\/j.cell.2010.07.002","journal-title":"Cell"},{"key":"10_CR14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.stemcr.2013.07.005","volume":"1","author":"JD Fu","year":"2013","unstructured":"Fu JD et al (2013) Direct reprogramming of human fibroblasts toward a cardiomyocyte-like state. Stem Cell Rep 1:235\u2013247. https:\/\/doi.org\/10.1016\/j.stemcr.2013.07.005","journal-title":"Stem Cell Rep"},{"key":"10_CR15","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/nprot.2013.067","volume":"8","author":"L Qian","year":"2013","unstructured":"Qian L, Berry EC, Fu JD, Ieda M, Srivastava D (2013) Reprogramming of mouse fibroblasts into cardiomyocyte-like cells in vitro. Nat Protoc 8:1204\u20131215. https:\/\/doi.org\/10.1038\/nprot.2013.067","journal-title":"Nat Protoc"},{"key":"10_CR16","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.yjmcc.2007.11.009","volume":"45","author":"P Menasche","year":"2008","unstructured":"Menasche P (2008) Skeletal myoblasts and cardiac repair. J Mol Cell Cardiol 45:545\u2013553. https:\/\/doi.org\/10.1016\/j.yjmcc.2007.11.009","journal-title":"J Mol Cell Cardiol"},{"key":"10_CR17","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nature06321","volume":"450","author":"W Roell","year":"2007","unstructured":"Roell W et al (2007) Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature 450:819\u2013824. https:\/\/doi.org\/10.1038\/nature06321","journal-title":"Nature"},{"key":"10_CR18","doi-asserted-by":"crossref","first-page":"I131","DOI":"10.1161\/01.cir.0000032889.55215.f1","volume":"106","author":"S Ghostine","year":"2002","unstructured":"Ghostine S et al (2002) Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 106:I131\u2013I136","journal-title":"Circulation"},{"key":"10_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41536-017-0024-1","volume":"2","author":"E Cambria","year":"2017","unstructured":"Cambria E et al (2017) Translational cardiac stem cell therapy: advancing from first-generation to next-generation cell types. NPJ Regen Med 2:17. https:\/\/doi.org\/10.1038\/s41536-017-0024-1","journal-title":"NPJ Regen Med"},{"key":"10_CR20","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.2527\/1990.68103441x","volume":"68","author":"RA Stock","year":"1990","unstructured":"Stock RA, Sindt MH, Parrott JC, Goedeken FK (1990) Effects of grain type, roughage level and monensin level on finishing cattle performance. J Anim Sci 68:3441\u20133455","journal-title":"J Anim Sci"},{"key":"10_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1006\/jmcc.2001.1507","volume":"34","author":"H Reinecke","year":"2002","unstructured":"Reinecke H, Poppa V, Murry CE (2002) Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol 34:241\u2013249. https:\/\/doi.org\/10.1006\/jmcc.2001.1507","journal-title":"J Mol Cell Cardiol"},{"key":"10_CR22","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1093\/eurheartj\/ehp342","volume":"31","author":"JJ Gavira","year":"2010","unstructured":"Gavira JJ et al (2010) Repeated implantation of skeletal myoblast in a swine model of chronic myocardial infarction. Eur Heart J 31:1013\u20131021. https:\/\/doi.org\/10.1093\/eurheartj\/ehp342","journal-title":"Eur Heart J"},{"key":"10_CR23","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/S0735-1097(03)00092-5","volume":"41","author":"P Menasche","year":"2003","unstructured":"Menasche P et al (2003) Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41:1078\u20131083","journal-title":"J Am Coll Cardiol"},{"key":"10_CR24","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.107.734103","volume":"117","author":"P Menasche","year":"2008","unstructured":"Menasche P et al (2008) The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 117:1189\u20131200. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.734103","journal-title":"Circulation"},{"key":"10_CR25","first-page":"975","volume":"142","author":"RH Hruban","year":"1993","unstructured":"Hruban RH et al (1993) Fluorescence in situ hybridization for the Y-chromosome can be used to detect cells of recipient origin in allografted hearts following cardiac transplantation. Am J Pathol 142:975\u2013980","journal-title":"Am J Pathol"},{"key":"10_CR26","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1161\/01.RES.0000014822.62629.EB","volume":"90","author":"MA Laflamme","year":"2002","unstructured":"Laflamme MA, Myerson D, Saffitz JE, Murry CE (2002) Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res 90:634\u2013640","journal-title":"Circ Res"},{"key":"10_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1161\/01.CIR.0000022405.68464.CA","volume":"106","author":"P Muller","year":"2002","unstructured":"Muller P et al (2002) Cardiomyocytes of noncardiac origin in myocardial biopsies of human transplanted hearts. Circulation 106:31\u201335","journal-title":"Circulation"},{"key":"10_CR28","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1172\/JCI12150","volume":"107","author":"KA Jackson","year":"2001","unstructured":"Jackson KA et al (2001) Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107:1395\u20131402. https:\/\/doi.org\/10.1172\/JCI12150","journal-title":"J Clin Invest"},{"key":"10_CR29","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1161\/01.CIR.0000061910.39145.F0","volume":"107","author":"A Deb","year":"2003","unstructured":"Deb A et al (2003) Bone marrow-derived cardiomyocytes are present in adult human heart: a study of gender-mismatched bone marrow transplantation patients. Circulation 107:1247\u20131249","journal-title":"Circulation"},{"key":"10_CR30","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1161\/CIRCRESAHA.113.300219","volume":"113","author":"SK Sanganalmath","year":"2013","unstructured":"Sanganalmath SK, Bolli R (2013) Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res 113:810\u2013834. https:\/\/doi.org\/10.1161\/CIRCRESAHA.113.300219","journal-title":"Circ Res"},{"key":"10_CR31","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1161\/CIRCRESAHA.118.314653","volume":"124","author":"B Vrtovec","year":"2019","unstructured":"Vrtovec B, Bolli R (2019) Potential strategies for clinical translation of repeated cell therapy. Circ Res 124:690\u2013692. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.314653","journal-title":"Circ Res"},{"key":"10_CR32","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1111\/jcmm.12632","volume":"19","author":"CH Chen","year":"2015","unstructured":"Chen CH, Sereti KI, Wu BM, Ardehali R (2015) Translational aspects of cardiac cell therapy. J Cell Mol Med 19:1757\u20131772. https:\/\/doi.org\/10.1111\/jcmm.12632","journal-title":"J Cell Mol Med"},{"issue":"Suppl 1","key":"10_CR33","doi-asserted-by":"publisher","first-page":"II247","DOI":"10.1161\/01.cir.0000089040.11131.d4","volume":"108","author":"A Bel","year":"2003","unstructured":"Bel A et al (2003) Transplantation of autologous fresh bone marrow into infarcted myocardium: a word of caution. Circulation 108(Suppl 1):II247\u2013II252. https:\/\/doi.org\/10.1161\/01.cir.0000089040.11131.d4","journal-title":"Circulation"},{"key":"10_CR34","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1093\/eurheartj\/ehn216","volume":"29","author":"R Silva de","year":"2008","unstructured":"de Silva R et al (2008) Intracoronary infusion of autologous mononuclear cells from bone marrow or granulocyte colony-stimulating factor-mobilized apheresis product may not improve remodelling, contractile function, perfusion, or infarct size in a swine model of large myocardial infarction. Eur Heart J 29:1772\u20131782. https:\/\/doi.org\/10.1093\/eurheartj\/ehn216","journal-title":"Eur Heart J"},{"key":"10_CR35","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1093\/eurheartj\/ehl401","volume":"27","author":"AD Moelker","year":"2006","unstructured":"Moelker AD et al (2006) Reduction in infarct size, but no functional improvement after bone marrow cell administration in a porcine model of reperfused myocardial infarction. Eur Heart J 27:3057\u20133064. https:\/\/doi.org\/10.1093\/eurheartj\/ehl401","journal-title":"Eur Heart J"},{"key":"10_CR36","doi-asserted-by":"publisher","first-page":"H125","DOI":"10.1152\/ajpheart.01260.2008","volume":"299","author":"JJ Graham","year":"2010","unstructured":"Graham JJ et al (2010) Long-term tracking of bone marrow progenitor cells following intracoronary injection post-myocardial infarction in swine using MRI. Am J Physiol Heart Circ Physiol 299:H125\u2013H133. https:\/\/doi.org\/10.1152\/ajpheart.01260.2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10_CR37","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/35070587","volume":"410","author":"D Orlic","year":"2001","unstructured":"Orlic D et al (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410:701\u2013705. https:\/\/doi.org\/10.1038\/35070587","journal-title":"Nature"},{"key":"10_CR38","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1161\/CIRCULATIONAHA.105.575118","volume":"113","author":"GP Meyer","year":"2006","unstructured":"Meyer GP et al (2006) Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113:1287\u20131294. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.575118","journal-title":"Circulation"},{"key":"10_CR39","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1056\/NEJMoa060186","volume":"355","author":"V Schachinger","year":"2006","unstructured":"Schachinger V et al (2006) Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355:1210\u20131221. https:\/\/doi.org\/10.1056\/NEJMoa060186","journal-title":"N Engl J Med"},{"key":"10_CR40","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1001\/jama.2012.28726","volume":"308","author":"JH Traverse","year":"2012","unstructured":"Traverse JH et al (2012) Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial. JAMA 308:2380\u20132389. https:\/\/doi.org\/10.1001\/jama.2012.28726","journal-title":"JAMA"},{"key":"10_CR41","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1161\/CIRCULATIONAHA.112.001035","volume":"127","author":"D Surder","year":"2013","unstructured":"Surder D et al (2013) Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function. Circulation 127:1968\u20131979. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.001035","journal-title":"Circulation"},{"key":"10_CR42","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1001\/jama.2012.418","volume":"307","author":"EC Perin","year":"2012","unstructured":"Perin EC et al (2012) Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. JAMA 307:1717\u20131726. https:\/\/doi.org\/10.1001\/jama.2012.418","journal-title":"JAMA"},{"key":"10_CR43","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1093\/eurheartj\/ehv559","volume":"37","author":"B Assmus","year":"2016","unstructured":"Assmus B et al (2016) Improved outcome with repeated intracoronary injection of bone marrow-derived cells within a registry: rationale for the randomized outcome trial REPEAT. Eur Heart J 37:1659\u20131666. https:\/\/doi.org\/10.1093\/eurheartj\/ehv559","journal-title":"Eur Heart J"},{"key":"10_CR44","first-page":"393","volume":"3","author":"AJ Friedenstein","year":"1970","unstructured":"Friedenstein AJ, Chailakhjan RK, Lalykina KS (1970) The development of fibroblast colonies in monolayer cultures of Guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3:393\u2013403","journal-title":"Cell Tissue Kinet"},{"key":"10_CR45","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315\u2013317. https:\/\/doi.org\/10.1080\/14653240600855905","journal-title":"Cytotherapy"},{"key":"10_CR46","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/path.2469","volume":"217","author":"AI Caplan","year":"2009","unstructured":"Caplan AI (2009) Why are MSCs therapeutic? New data: new insight. J Pathol 217:318\u2013324. https:\/\/doi.org\/10.1002\/path.2469","journal-title":"J Pathol"},{"key":"10_CR47","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1478-811X-9-12","volume":"9","author":"R Hass","year":"2011","unstructured":"Hass R, Kasper C, Bohm S, Jacobs R (2011) Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal 9:12. https:\/\/doi.org\/10.1186\/1478-811X-9-12","journal-title":"Cell Commun Signal"},{"key":"10_CR48","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41551-018-0325-8","volume":"3","author":"JQ Yin","year":"2019","unstructured":"Yin JQ, Zhu J, Ankrum JA (2019) Manufacturing of primed mesenchymal stromal cells for therapy. Nat Biomed Eng 3:90\u2013104. https:\/\/doi.org\/10.1038\/s41551-018-0325-8","journal-title":"Nat Biomed Eng"},{"key":"10_CR49","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s00018-013-1462-6","volume":"71","author":"IR Murray","year":"2014","unstructured":"Murray IR et al (2014) Natural history of mesenchymal stem cells, from vessel walls to culture vessels. Cell Mol Life Sci 71:1353\u20131374. https:\/\/doi.org\/10.1007\/s00018-013-1462-6","journal-title":"Cell Mol Life Sci"},{"key":"10_CR50","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.stem.2008.07.003","volume":"3","author":"M Crisan","year":"2008","unstructured":"Crisan M et al (2008) A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3:301\u2013313. https:\/\/doi.org\/10.1016\/j.stem.2008.07.003","journal-title":"Cell Stem Cell"},{"issue":"7","key":"10_CR51","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/sctm.16-0492","volume":"6","author":"John E. Davies","year":"2017","unstructured":"Davies JE, Walker JT, Keating A (2017) Concise review: Wharton\u2019s jelly: the rich, but enigmatic, source of Mesenchymal Stromal. Cells Stem Cells Transl Med 6:1620\u20131630. https:\/\/doi.org\/10.1002\/sctm.16-0492","journal-title":"STEM CELLS Translational Medicine"},{"key":"10_CR52","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1089\/107632701300062859","volume":"7","author":"PA Zuk","year":"2001","unstructured":"Zuk PA et al (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7:211\u2013228. https:\/\/doi.org\/10.1089\/107632701300062859","journal-title":"Tissue Eng"},{"key":"10_CR53","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1161\/CIRCRESAHA.116.303614","volume":"116","author":"V Karantalis","year":"2015","unstructured":"Karantalis V, Hare JM (2015) Use of mesenchymal stem cells for therapy of cardiac disease. Circ Res 116:1413\u20131430. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.303614","journal-title":"Circ Res"},{"key":"10_CR54","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1161\/CIRCRESAHA.117.310712","volume":"121","author":"J Bartolucci","year":"2017","unstructured":"Bartolucci J et\u00a0al (2017) Safety and efficacy of the intravenous infusion of umbilical cord mesenchymal stem cells in patients with heart failure: a phase 1\/2 randomized controlled trial (RIMECARD trial [randomized clinical trial of intravenous infusion umbilical cord mesenchymal stem cells on cardiopathy]). Circ Res 121:1192\u20131204. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.310712","journal-title":"Circ Res"},{"key":"10_CR55","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1634\/stemcells.2004-0013","volume":"22","author":"HS Wang","year":"2004","unstructured":"Wang HS et al (2004) Mesenchymal stem cells in the Wharton\u2019s jelly of the human umbilical cord. Stem Cells 22:1330\u20131337. https:\/\/doi.org\/10.1634\/stemcells.2004-0013","journal-title":"Stem Cells"},{"key":"10_CR56","doi-asserted-by":"publisher","first-page":"100","DOI":"10.5114\/pwki.2015.52282","volume":"11","author":"P Musialek","year":"2015","unstructured":"Musialek P et al (2015) Myocardial regeneration strategy using Wharton\u2019s jelly mesenchymal stem cells as an off-the-shelf \u2018unlimited\u2019 therapeutic agent: results from the Acute Myocardial Infarction First-in-Man Study. Postepy Kardiol Interwencyjnej 11:100\u2013107. https:\/\/doi.org\/10.5114\/pwki.2015.52282","journal-title":"Postepy Kardiol Interwencyjnej"},{"key":"10_CR57","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1046\/j.1365-2141.2000.01986.x","volume":"109","author":"A Erices","year":"2000","unstructured":"Erices A, Conget P, Minguell JJ (2000) Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109:235\u2013242","journal-title":"Br J Haematol"},{"key":"10_CR58","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12916-015-0399-z","volume":"13","author":"LR Gao","year":"2015","unstructured":"Gao LR et al (2015) Intracoronary infusion of Wharton\u2019s jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial. BMC Med 13:162. https:\/\/doi.org\/10.1186\/s12916-015-0399-z","journal-title":"BMC Med"},{"key":"10_CR59","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/scrt488","volume":"5","author":"P Lohan","year":"2014","unstructured":"Lohan P et al (2014) Changes in immunological profile of allogeneic mesenchymal stem cells after differentiation: should we be concerned? Stem Cell Res Ther 5:99. https:\/\/doi.org\/10.1186\/scrt488","journal-title":"Stem Cell Res Ther"},{"key":"10_CR60","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nbt.2816","volume":"32","author":"JA Ankrum","year":"2014","unstructured":"Ankrum JA, Ong JF, Karp JM (2014) Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol 32:252\u2013260. https:\/\/doi.org\/10.1038\/nbt.2816","journal-title":"Nat Biotechnol"},{"key":"10_CR61","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/eurheartj\/ehm559","volume":"29","author":"SM Hashemi","year":"2008","unstructured":"Hashemi SM et al (2008) A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction. Eur Heart J 29:251\u2013259. https:\/\/doi.org\/10.1093\/eurheartj\/ehm559","journal-title":"Eur Heart J"},{"key":"10_CR62","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1161\/CIRCIMAGING.108.797449","volume":"1","author":"M Gyongyosi","year":"2008","unstructured":"Gyongyosi M et al (2008) Serial noninvasive in vivo positron emission tomographic tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expression. Circ Cardiovasc Imaging 1:94\u2013103. https:\/\/doi.org\/10.1161\/CIRCIMAGING.108.797449","journal-title":"Circ Cardiovasc Imaging"},{"key":"10_CR63","doi-asserted-by":"publisher","first-page":"S220","DOI":"10.1161\/CIRCULATIONAHA.108.842302","volume":"120","author":"JA Dixon","year":"2009","unstructured":"Dixon JA et al (2009) Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction. Circulation 120:S220\u2013S229. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.842302","journal-title":"Circulation"},{"key":"10_CR64","doi-asserted-by":"publisher","first-page":"14022","DOI":"10.1073\/pnas.0903201106","volume":"106","author":"HC Quevedo","year":"2009","unstructured":"Quevedo HC et al (2009) Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci U S A 106:14022\u201314027. https:\/\/doi.org\/10.1073\/pnas.0903201106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10_CR65","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1161\/CIRCRESAHA.110.222703","volume":"107","author":"KE Hatzistergos","year":"2010","unstructured":"Hatzistergos KE et al (2010) Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res 107:913\u2013922. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.222703","journal-title":"Circ Res"},{"key":"10_CR66","doi-asserted-by":"publisher","first-page":"e000140","DOI":"10.1161\/JAHA.113.000140","volume":"2","author":"AR Williams","year":"2013","unstructured":"Williams AR et al (2013) Durable scar size reduction due to allogeneic mesenchymal stem cell therapy regulates whole-chamber remodeling. J Am Heart Assoc 2:e000140. https:\/\/doi.org\/10.1161\/JAHA.113.000140","journal-title":"J Am Heart Assoc"},{"key":"10_CR67","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1161\/hc0102.101442","volume":"105","author":"C Toma","year":"2002","unstructured":"Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD (2002) Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105:93\u201398","journal-title":"Circulation"},{"key":"10_CR68","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1172\/JCI5298","volume":"103","author":"S Makino","year":"1999","unstructured":"Makino S et al (1999) Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103:697\u2013705. https:\/\/doi.org\/10.1172\/JCI5298","journal-title":"J Clin Invest"},{"key":"10_CR69","doi-asserted-by":"publisher","unstructured":"Szaraz P, Gratch YS, Iqbal F, Librach CL (2017) In vitro differentiation of human mesenchymal stem cells into functional cardiomyocyte-like cells. J Vis Exp. https:\/\/doi.org\/10.3791\/55757","DOI":"10.3791\/55757"},{"key":"10_CR70","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1423-0410.2008.01076.x","volume":"95","author":"E Martin-Rendon","year":"2008","unstructured":"Martin-Rendon E et al (2008) 5-Azacytidine-treated human mesenchymal stem\/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. Vox Sang 95:137\u2013148. https:\/\/doi.org\/10.1111\/j.1423-0410.2008.01076.x","journal-title":"Vox Sang"},{"key":"10_CR71","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1161\/CIRCRESAHA.117.310954","volume":"120","author":"T Hamid","year":"2017","unstructured":"Hamid T, Prabhu SD (2017) Immunomodulation is the key to cardiac repair. Circ Res 120:1530\u20131532. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.310954","journal-title":"Circ Res"},{"key":"10_CR72","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.yjmcc.2006.10.003","volume":"42","author":"S Ohnishi","year":"2007","unstructured":"Ohnishi S et al (2007) Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis. J Mol Cell Cardiol 42:88\u201397. https:\/\/doi.org\/10.1016\/j.yjmcc.2006.10.003","journal-title":"J Mol Cell Cardiol"},{"issue":"32","key":"10_CR73","doi-asserted-by":"publisher","first-page":"11474","DOI":"10.1073\/pnas.0504388102","volume":"102","author":"L. C. Amado","year":"2005","unstructured":"Amado LC et al (2005) Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A 102:11474\u201311479. https:\/\/doi.org\/10.1073\/pnas.0504388102","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"2","key":"10_CR74","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1161\/01.CIR.0000151812.86142.45","volume":"111","author":"Guilherme V. Silva","year":"2005","unstructured":"Silva GV et al (2005) Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111:150\u2013156. https:\/\/doi.org\/10.1161\/01.CIR.0000151812.86142.45","journal-title":"Circulation"},{"issue":"5","key":"10_CR75","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1073\/pnas.0610024104","volume":"104","author":"M. Mirotsou","year":"2007","unstructured":"Mirotsou M et al (2007) Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc Natl Acad Sci U S A 104:1643\u20131648. https:\/\/doi.org\/10.1073\/pnas.0610024104","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"3","key":"10_CR76","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.scr.2009.12.003","volume":"4","author":"Ruenn Chai Lai","year":"2010","unstructured":"Lai RC et al (2010) Exosome secreted by MSC reduces myocardial ischemia\/reperfusion injury. Stem Cell Res 4:214\u2013222. https:\/\/doi.org\/10.1016\/j.scr.2009.12.003","journal-title":"Stem Cell Research"},{"issue":"22","key":"10_CR77","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1093\/eurheartj\/ehp265","volume":"30","author":"K. H. Schuleri","year":"2009","unstructured":"Schuleri KH et al (2009) Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. Eur Heart J 30:2722\u20132732. https:\/\/doi.org\/10.1093\/eurheartj\/ehp265","journal-title":"European Heart Journal"},{"issue":"10","key":"10_CR78","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1016\/j.jacc.2006.06.073","volume":"48","author":"Luciano C. Amado","year":"2006","unstructured":"Amado LC et al (2006) Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy. J Am Coll Cardiol 48:2116\u20132124. https:\/\/doi.org\/10.1016\/j.jacc.2006.06.073","journal-title":"Journal of the American College of Cardiology"},{"issue":"24","key":"10_CR79","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1016\/j.jacc.2009.06.055","volume":"54","author":"Joshua M. Hare","year":"2009","unstructured":"Hare JM et al (2009) A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 54:2277\u20132286. https:\/\/doi.org\/10.1016\/j.jacc.2009.06.055","journal-title":"Journal of the American College of Cardiology"},{"issue":"5","key":"10_CR80","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1007\/s12265-013-9507-7","volume":"6","author":"Sander F. Rodrigo","year":"2013","unstructured":"Rodrigo SF et al (2013) Intramyocardial injection of autologous bone marrow-derived ex vivo expanded mesenchymal stem cells in acute myocardial infarction patients is feasible and safe up to 5 years of follow-up. J Cardiovasc Transl Res 6:816\u2013825. https:\/\/doi.org\/10.1007\/s12265-013-9507-7","journal-title":"Journal of Cardiovascular Translational Research"},{"issue":"5","key":"10_CR81","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jacc.2011.09.065","volume":"59","author":"Jaco H. Houtgraaf","year":"2012","unstructured":"Houtgraaf JH et al (2012) First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 59:539\u2013540. https:\/\/doi.org\/10.1016\/j.jacc.2011.09.065","journal-title":"Journal of the American College of Cardiology"},{"issue":"22","key":"10_CR82","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1001\/jama.2012.25321","volume":"308","author":"Joshua M. Hare","year":"2012","unstructured":"Hare JM et al (2012) Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA 308:2369\u20132379. https:\/\/doi.org\/10.1001\/jama.2012.25321","journal-title":"JAMA"},{"issue":"1","key":"10_CR83","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/jama.2013.282909","volume":"311","author":"Alan W. Heldman","year":"2014","unstructured":"Heldman AW et al (2014) Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. JAMA 311:62\u201373. https:\/\/doi.org\/10.1001\/jama.2013.282909","journal-title":"JAMA"},{"issue":"27","key":"10_CR84","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1093\/eurheartj\/ehv136","volume":"36","author":"Anders Bruun Mathiasen","year":"2015","unstructured":"Mathiasen AB et al (2015) Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial). Eur Heart J 36:1744\u20131753. https:\/\/doi.org\/10.1093\/eurheartj\/ehv136","journal-title":"European Heart Journal"},{"issue":"23","key":"10_CR85","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/j.jacc.2013.02.071","volume":"61","author":"Jozef Bartunek","year":"2013","unstructured":"Bartunek J et\u00a0al (2013) Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. J Am Coll Cardiol 61:2329\u20132338. https:\/\/doi.org\/10.1016\/j.jacc.2013.02.071","journal-title":"Journal of the American College of Cardiology"},{"issue":"9","key":"10_CR86","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.jacc.2010.03.066","volume":"56","author":"Atta Behfar","year":"2010","unstructured":"Behfar A et al (2010) Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J Am Coll Cardiol 56:721\u2013734. https:\/\/doi.org\/10.1016\/j.jacc.2010.03.066","journal-title":"Journal of the American College of Cardiology"},{"issue":"11","key":"10_CR87","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1002\/ejhf.898","volume":"19","author":"John R. Teerlink","year":"2017","unstructured":"Teerlink JR et al (2017) Benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) study. Eur J Heart Fail 19:1520\u20131529. https:\/\/doi.org\/10.1002\/ejhf.898","journal-title":"European Journal of Heart Failure"},{"key":"10_CR88","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1002\/ejhf.955","volume":"19","author":"BA Tompkins","year":"2017","unstructured":"Tompkins BA, Rieger AC, Florea V, Banerjee MN, Hare JM (2017) New insights into cell-based therapy for heart failure from the CHART-1 study. Eur J Heart Fail 19:1530\u20131533. https:\/\/doi.org\/10.1002\/ejhf.955","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"10_CR89","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa055706","volume":"355","author":"Ketil Lunde","year":"2006","unstructured":"Lunde K et al (2006) Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355:1199\u20131209. https:\/\/doi.org\/10.1056\/NEJMoa055706","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10_CR90","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1161\/CIRCULATIONAHA.111.086074","volume":"126","author":"Vinodh Jeevanantham","year":"2012","unstructured":"Jeevanantham V et al (2012) Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation 126:551\u2013568. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.086074","journal-title":"Circulation"},{"issue":"6","key":"10_CR91","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1161\/CIRCRESAHA.114.304792","volume":"117","author":"Muhammad R. Afzal","year":"2015","unstructured":"Afzal MR et al (2015) Adult bone marrow cell therapy for ischemic heart disease: evidence and insights from randomized controlled trials. Circ Res 117:558\u2013575. https:\/\/doi.org\/10.1161\/CIRCRESAHA.114.304792","journal-title":"Circulation Research"},{"issue":"10","key":"10_CR92","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1001\/archinte.167.10.989","volume":"167","author":"Ahmed Abdel-Latif","year":"2007","unstructured":"Abdel-Latif A et al (2007) Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 167:989\u2013997. https:\/\/doi.org\/10.1001\/archinte.167.10.989","journal-title":"Archives of Internal Medicine"},{"key":"10_CR93","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/cvr\/cvn081","volume":"78","author":"A Zampetaki","year":"2008","unstructured":"Zampetaki A, Kirton JP, Xu Q (2008) Vascular repair by endothelial progenitor cells. Cardiovasc Res 78:413\u2013421. https:\/\/doi.org\/10.1093\/cvr\/cvn081","journal-title":"Cardiovasc Res"},{"key":"10_CR94","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1126\/science.275.5302.964","volume":"275","author":"T Asahara","year":"1997","unstructured":"Asahara T et al (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964\u2013967","journal-title":"Science"},{"issue":"5","key":"10_CR95","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/sctm.16-0360","volume":"6","author":"Reinhold J. Medina","year":"2017","unstructured":"Medina RJ et al (2017) Endothelial progenitors: a consensus statement on nomenclature. Stem Cells Transl Med 6:1316\u20131320. https:\/\/doi.org\/10.1002\/sctm.16-0360","journal-title":"STEM CELLS Translational Medicine"},{"key":"10_CR96","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1002\/stem.745","volume":"29","author":"T Asahara","year":"2011","unstructured":"Asahara T, Kawamoto A, Masuda H (2011) Concise review: circulating endothelial progenitor cells for vascular medicine. Stem Cells 29:1650\u20131655. https:\/\/doi.org\/10.1002\/stem.745","journal-title":"Stem Cells"},{"key":"10_CR97","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12967-017-1280-y","volume":"15","author":"RK Ambasta","year":"2017","unstructured":"Ambasta RK, Kohli H, Kumar P (2017) Multiple therapeutic effect of endothelial progenitor cell regulated by drugs in diabetes and diabetes related disorder. J Transl Med 15:185. https:\/\/doi.org\/10.1186\/s12967-017-1280-y","journal-title":"J Transl Med"},{"key":"10_CR98","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.pharmthera.2017.08.004","volume":"181","author":"Vanessa Bianconi","year":"2018","unstructured":"Bianconi V et al (2018) Endothelial and cardiac progenitor cells for cardiovascular repair: a controversial paradigm in cell therapy. Pharmacol Ther 181:156\u2013168. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.08.004","journal-title":"Pharmacology & Therapeutics"},{"key":"10_CR99","doi-asserted-by":"publisher","unstructured":"Kalka C et al (2000) Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 97:3422\u20133427. https:\/\/doi.org\/10.1073\/pnas.070046397","DOI":"10.1073\/pnas.070046397"},{"key":"10_CR100","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1161\/01.CIR.103.5.634","volume":"103","author":"A Kawamoto","year":"2001","unstructured":"Kawamoto A et al (2001) Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103:634\u2013637","journal-title":"Circulation"},{"issue":"4","key":"10_CR101","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1161\/CIRCRESAHA.111.245993","volume":"109","author":"Douglas W. Losordo","year":"2011","unstructured":"Losordo DW et al (2011) Intramyocardial, autologous CD34+ cell therapy for refractory angina. Circ Res 109:428\u2013436. https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.245993","journal-title":"Circulation Research"},{"key":"10_CR102","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.2147\/TCRM.S107199","volume":"Volume 12","author":"Rong Li","year":"2016","unstructured":"Li R, Li XM, Chen JR (2016) Clinical efficacy and safety of autologous stem cell transplantation for patients with ST-segment elevation myocardial infarction. Ther Clin Risk Manag 12:1171\u20131189. https:\/\/doi.org\/10.2147\/TCRM.S107199","journal-title":"Therapeutics and Clinical Risk Management"},{"issue":"3","key":"10_CR103","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.carrev.2018.05.018","volume":"20","author":"Poonam Velagapudi","year":"2019","unstructured":"Velagapudi P et al (2019) Intramyocardial autologous CD34+ cell therapy for refractory angina: a meta-analysis of randomized controlled trials. Cardiovasc Revasc Med 20:215\u2013219. https:\/\/doi.org\/10.1016\/j.carrev.2018.05.018","journal-title":"Cardiovascular Revascularization Medicine"},{"issue":"8","key":"10_CR104","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.jacc.2004.08.014","volume":"44","author":"Volker Sch\u00e4chinger","year":"2004","unstructured":"Schachinger V et al (2004) Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 44:1690\u20131699. https:\/\/doi.org\/10.1016\/j.jacc.2004.08.014","journal-title":"Journal of the American College of Cardiology"},{"key":"10_CR105","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41569-018-0036-6","volume":"15","author":"H Hashimoto","year":"2018","unstructured":"Hashimoto H, Olson EN, Bassel-Duby R (2018) Therapeutic approaches for cardiac regeneration and repair. Nat Rev Cardiol 15:585\u2013600. https:\/\/doi.org\/10.1038\/s41569-018-0036-6","journal-title":"Nat Rev Cardiol"},{"issue":"21","key":"10_CR106","doi-asserted-by":"publisher","first-page":"12313","DOI":"10.1073\/pnas.2132126100","volume":"100","author":"H. Oh","year":"2003","unstructured":"Oh H et al (2003) Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A 100:12313\u201312318. https:\/\/doi.org\/10.1073\/pnas.2132126100","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"7026","key":"10_CR107","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nature03215","volume":"433","author":"Karl-Ludwig Laugwitz","year":"2005","unstructured":"Laugwitz KL et al (2005) Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433:647\u2013653. https:\/\/doi.org\/10.1038\/nature03215","journal-title":"Nature"},{"issue":"9","key":"10_CR108","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/01.RES.0000147315.71699.51","volume":"95","author":"Elisa Messina","year":"2004","unstructured":"Messina E et al (2004) Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 95:911\u2013921. https:\/\/doi.org\/10.1161\/01.RES.0000147315.71699.51","journal-title":"Circulation Research"},{"issue":"9925","key":"10_CR109","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/S0140-6736(14)60608-5","volume":"383","author":"The Lancet Editors","year":"2014","unstructured":"The Lancet, E. Expression of concern: the SCIPIO trial. Lancet 383:1279. https:\/\/doi.org\/10.1016\/S0140-6736(14)60608-5","journal-title":"The Lancet"},{"issue":"9","key":"10_CR110","doi-asserted-by":"publisher","first-page":"e7195","DOI":"10.1371\/journal.pone.0007195","volume":"4","author":"Darryl R. Davis","year":"2009","unstructured":"Davis DR et al (2009) Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue. PLoS One 4:e7195. https:\/\/doi.org\/10.1371\/journal.pone.0007195","journal-title":"PLoS ONE"},{"issue":"7","key":"10_CR111","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1161\/CIRCULATIONAHA.106.655209","volume":"115","author":"Rachel Ruckdeschel Smith","year":"2007","unstructured":"Smith RR et al (2007) Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115:896\u2013908. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.655209","journal-title":"Circulation"},{"issue":"12","key":"10_CR112","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.108.816058","volume":"120","author":"Peter V. Johnston","year":"2009","unstructured":"Johnston PV et al (2009) Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation 120:1075\u20131083, 1077 p following 1083. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.816058","journal-title":"Circulation"},{"issue":"5","key":"10_CR113","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1161\/CIRCRESAHA.109.210682","volume":"106","author":"Isotta Chimenti","year":"2010","unstructured":"Chimenti I et al (2010) Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res 106:971\u2013980. https:\/\/doi.org\/10.1161\/CIRCRESAHA.109.210682","journal-title":"Circulation Research"},{"issue":"8","key":"10_CR114","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1161\/CIRCRESAHA.115.307676","volume":"118","author":"Peter Paul Zwetsloot","year":"2016","unstructured":"Zwetsloot PP et al (2016) Cardiac stem cell treatment in myocardial infarction: a systematic review and meta-analysis of preclinical studies. Circ Res 118:1223\u20131232. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.307676","journal-title":"Circulation Research"},{"issue":"9819","key":"10_CR115","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0140-6736(12)60195-0","volume":"379","author":"Raj R Makkar","year":"2012","unstructured":"Makkar RR et al (2012) Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 379:895\u2013904. https:\/\/doi.org\/10.1016\/S0140-6736(12)60195-0","journal-title":"The Lancet"},{"issue":"2","key":"10_CR116","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jacc.2013.08.724","volume":"63","author":"Konstantinos Malliaras","year":"2014","unstructured":"Malliaras K et al (2014) Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction). J Am Coll Cardiol 63:110\u2013122. doi: https:\/\/doi.org\/10.1016\/j.jacc.2013.08.724","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"10_CR117","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1161\/CIRCULATIONAHA.112.131110","volume":"127","author":"Adam R. Williams","year":"2013","unstructured":"Williams AR et al (2013) Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation 127:213\u2013223. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.131110","journal-title":"Circulation"},{"issue":"18","key":"10_CR118","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/j.jacc.2015.08.879","volume":"66","author":"Vasileios Karantalis","year":"2015","unstructured":"Karantalis V et al (2015) Synergistic effects of combined cell therapy for chronic ischemic cardiomyopathy. J Am Coll Cardiol 66:1990\u20131999. https:\/\/doi.org\/10.1016\/j.jacc.2015.08.879","journal-title":"Journal of the American College of Cardiology"},{"issue":"7400","key":"10_CR119","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nature11044","volume":"485","author":"Li Qian","year":"2012","unstructured":"Qian L et al (2012) In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 485:593\u2013598. doi: https:\/\/doi.org\/10.1038\/nature11044","journal-title":"Nature"},{"issue":"12","key":"10_CR120","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.5966\/sctm.2015-0136","volume":"4","author":"Xiao-Hong Li","year":"2015","unstructured":"Li XH et al (2015) Generation of functional human cardiac progenitor cells by high-efficiency protein transduction. Stem Cells Transl Med 4:1415\u20131424. https:\/\/doi.org\/10.5966\/sctm.2015-0136","journal-title":"STEM CELLS Translational Medicine"},{"key":"10_CR121","doi-asserted-by":"publisher","unstructured":"Lee K et al (2015) Peptide-enhanced mRNA transfection in cultured mouse cardiac fibroblasts and direct reprogramming towards cardiomyocyte-like cells. Int J Nanomedicine 10:1841\u20131854. https:\/\/doi.org\/10.2147\/IJN.S75124","DOI":"10.2147\/IJN.S75124"},{"issue":"5923","key":"10_CR122","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1126\/science.1164680","volume":"324","author":"Olaf Bergmann","year":"2009","unstructured":"Bergmann O et al (2009) Evidence for cardiomyocyte renewal in humans. Science 324, 98\u2013102, doi: https:\/\/doi.org\/10.1126\/science.1164680","journal-title":"Science"},{"issue":"7432","key":"10_CR123","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nature11682","volume":"493","author":"Samuel E. Senyo","year":"2012","unstructured":"Senyo SE et al (2013) Mammalian heart renewal by pre-existing cardiomyocytes. Nature 493:433\u2013436. https:\/\/doi.org\/10.1038\/nature11682","journal-title":"Nature"},{"issue":"24","key":"10_CR124","doi-asserted-by":"publisher","first-page":"8850","DOI":"10.1073\/pnas.1408233111","volume":"111","author":"S. R. Ali","year":"2014","unstructured":"Ali SR et al (2014) Existing cardiomyocytes generate cardiomyocytes at a low rate after birth in mice. Proc Natl Acad Sci U S A 111:8850\u20138855. https:\/\/doi.org\/10.1073\/pnas.1408233111","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10_CR125","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/cvr\/cvq005","volume":"86","author":"S Walsh","year":"2010","unstructured":"Walsh S, Ponten A, Fleischmann BK, Jovinge S (2010) Cardiomyocyte cell cycle control and growth estimation in vivo\u2013an analysis based on cardiomyocyte nuclei. Cardiovasc Res 86:365\u2013373. https:\/\/doi.org\/10.1093\/cvr\/cvq005","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10_CR126","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1161\/CIRCRESAHA.116.309710","volume":"120","author":"Chen-Leng Cai","year":"2017","unstructured":"Cai CL, Molkentin JD (2017) The elusive progenitor cell in cardiac regeneration: Slip Slidin\u2019 away. Circ Res 120:400\u2013406. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.309710","journal-title":"Circulation Research"},{"issue":"4","key":"10_CR127","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1073\/pnas.1214608110","volume":"110","author":"Mariya Mollova","year":"2013","unstructured":"Mollova M et al (2013) Cardiomyocyte proliferation contributes to heart growth in young humans. Proc Natl Acad Sci U S A 110:1446\u20131451. https:\/\/doi.org\/10.1073\/pnas.1214608110","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10_CR128","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1126\/science.1077857","volume":"298","author":"KD Poss","year":"2002","unstructured":"Poss KD, Wilson LG, Keating MT (2002) Heart regeneration in zebrafish. Science 298:2188\u20132190. https:\/\/doi.org\/10.1126\/science.1077857","journal-title":"Science"},{"issue":"23","key":"10_CR129","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1242\/dev.102798","volume":"140","author":"T. Heallen","year":"2013","unstructured":"Heallen T et al (2013) Hippo signaling impedes adult heart regeneration. Development 140:4683\u20134690. https:\/\/doi.org\/10.1242\/dev.102798","journal-title":"Development"},{"issue":"34","key":"10_CR130","doi-asserted-by":"publisher","first-page":"13839","DOI":"10.1073\/pnas.1313192110","volume":"110","author":"Mei Xin","year":"2013","unstructured":"Xin M et al (2013) Hippo pathway effector Yap promotes cardiac regeneration. Proc Natl Acad Sci U S A 110:13839\u201313844. https:\/\/doi.org\/10.1073\/pnas.1313192110","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"7675","key":"10_CR131","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/nature24045","volume":"550","author":"John P. Leach","year":"2017","unstructured":"Leach JP et al (2017) Hippo pathway deficiency reverses systolic heart failure after infarction. Nature 550:260\u2013264. https:\/\/doi.org\/10.1038\/nature24045","journal-title":"Nature"},{"issue":"12","key":"10_CR132","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1161\/CIRCRESAHA.107.153544","volume":"100","author":"Richard K. Cheng","year":"2007","unstructured":"Cheng RK et al (2007) Cyclin A2 induces cardiac regeneration after myocardial infarction and prevents heart failure. Circ Res 100:1741\u20131748. https:\/\/doi.org\/10.1161\/CIRCRESAHA.107.153544","journal-title":"Circulation Research"},{"issue":"224","key":"10_CR133","doi-asserted-by":"publisher","first-page":"224ra27","DOI":"10.1126\/scitranslmed.3007668","volume":"6","author":"S. D. Shapiro","year":"2014","unstructured":"Shapiro SD et al (2014) Cyclin A2 induces cardiac regeneration after myocardial infarction through cytokinesis of adult cardiomyocytes. Sci Transl Med 6:224ra227. https:\/\/doi.org\/10.1126\/scitranslmed.3007668","journal-title":"Science Translational Medicine"},{"issue":"1_suppl","key":"10_CR134","doi-asserted-by":"publisher","first-page":"I-206-I-213","DOI":"10.1161\/CIRCULATIONAHA.105.000455","volume":"114","author":"Y. J. Woo","year":"2006","unstructured":"Woo YJ et al (2006) Therapeutic delivery of cyclin A2 induces myocardial regeneration and enhances cardiac function in ischemic heart failure. Circulation 114:I206\u2013213. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.000455","journal-title":"Circulation"},{"key":"10_CR135","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.addr.2014.08.006","volume":"84","author":"Conn L. Hastings","year":"2015","unstructured":"Hastings CL et al (2015) Drug and cell delivery for cardiac regeneration. Adv Drug Deliv Rev 84:85\u2013106. https:\/\/doi.org\/10.1016\/j.addr.2014.08.006","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"9","key":"10_CR136","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.117.310738","volume":"120","author":"Florian Weinberger","year":"2017","unstructured":"Weinberger F, Mannhardt I, Eschenhagen T (2017) Engineering cardiac muscle tissue: a maturating field of research. Circ Res 120:1487\u20131500. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.310738","journal-title":"Circulation Research"},{"issue":"342","key":"10_CR137","doi-asserted-by":"publisher","first-page":"342ps13","DOI":"10.1126\/scitranslmed.aad2304","volume":"8","author":"Brenda M. Ogle","year":"2016","unstructured":"Ogle BM et al (2016) Distilling complexity to advance cardiac tissue engineering. Sci Transl Med 8:342ps313. https:\/\/doi.org\/10.1126\/scitranslmed.aad2304","journal-title":"Science Translational Medicine"},{"issue":"27","key":"10_CR138","doi-asserted-by":"publisher","first-page":"6339","DOI":"10.1016\/j.biomaterials.2013.04.034","volume":"34","author":"Maximilian Y. Emmert","year":"2013","unstructured":"Emmert MY et al. (2013) Human stem cell-based three-dimensional microtissues for advanced cardiac cell therapies. Biomaterials 34:6339\u20136354. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.04.034","journal-title":"Biomaterials"},{"key":"10_CR139","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.tibtech.2018.01.005","volume":"36","author":"A Ovsianikov","year":"2018","unstructured":"Ovsianikov A, Khademhosseini A, Mironov V (2018) The synergy of scaffold-based and scaffold-free tissue engineering strategies. Trends Biotechnol 36:348\u2013357. https:\/\/doi.org\/10.1016\/j.tibtech.2018.01.005","journal-title":"Trends Biotechnol"},{"issue":"6","key":"10_CR140","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1152\/japplphysiol.01109.2007","volume":"104","author":"Ting C. Zhao","year":"2008","unstructured":"Zhao TC et al (2008) Targeting human CD34+ hematopoietic stem cells with anti-CD45 x anti-myosin light-chain bispecific antibody preserves cardiac function in myocardial infarction. J Appl Physiol (1985) 104:1793\u20131800. https:\/\/doi.org\/10.1152\/japplphysiol.01109.2007","journal-title":"Journal of Applied Physiology"},{"issue":"4","key":"10_CR141","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3390\/biom8040147","volume":"8","author":"Maliha Zahid","year":"2018","unstructured":"Zahid M et al (2018) Cardiac targeting peptide, a novel cardiac vector: studies in bio-distribution, imaging application, and mechanism of transduction. Biomolecules 8. https:\/\/doi.org\/10.3390\/biom8040147","journal-title":"Biomolecules"},{"issue":"4","key":"10_CR142","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.bbrc.2018.03.227","volume":"499","author":"Hyoeun Kim","year":"2018","unstructured":"Kim H et al (2018) Cardiac-specific delivery by cardiac tissue-targeting peptide-expressing exosomes. Biochem Biophys Res Commun 499:803\u2013808. https:\/\/doi.org\/10.1016\/j.bbrc.2018.03.227","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"5","key":"10_CR143","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41551-018-0227-9","volume":"2","author":"Mikyung Shin","year":"2018","unstructured":"Shin M et al (2018) Targeting protein and peptide therapeutics to the heart via tannic acid modification. Nat Biomed Eng 2:304\u2013317. https:\/\/doi.org\/10.1038\/s41551-018-0227-9","journal-title":"Nature Biomedical Engineering"},{"issue":"10","key":"10_CR144","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1161\/CIRCRESAHA.109.197723","volume":"104","author":"Yao Liang Tang","year":"2009","unstructured":"Tang YL et al (2009) Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circ Res 104:1209\u20131216. https:\/\/doi.org\/10.1161\/CIRCRESAHA.109.197723","journal-title":"Circulation Research"},{"issue":"7","key":"10_CR145","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1161\/CIRCRESAHA.117.310710","volume":"120","author":"Roberto Bolli","year":"2017","unstructured":"Bolli R Repeated cell therapy: a paradigm shift whose time has come. Circ Res 120:1072\u20131074. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.310710","journal-title":"Circulation Research"},{"issue":"5","key":"10_CR146","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1161\/CIRCRESAHA.116.308937","volume":"119","author":"Yukichi Tokita","year":"2016","unstructured":"Tokita Y et al (2016) Repeated administrations of cardiac progenitor cells are markedly more effective than a single administration: a new paradigm in cell therapy. Circ Res 119:635\u2013651. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.308937","journal-title":"Circulation Research"}],"container-title":["Advances in Experimental Medicine and Biology","Stem Cells"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-31206-0_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,9]],"date-time":"2022-10-09T18:29:22Z","timestamp":1665340162000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-31206-0_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030312053","9783030312060"],"references-count":146,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-31206-0_10","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"3 January 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}